• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IXC 0.00% 7.3¢

INVEX THERAPEUTICS LTD

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IXC 07/02/25 0 140
07/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  140 
IXC 22/01/25 0 267
22/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  267 
IXC 20/01/25 0 223
TRENDING NEWS

HotCopper Highlights: Your most watched stocks for Week 6, 2025

NEWS
08 Feb 2025
20/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  223 
IXC 27/12/24 4 1.7K
27/12/24 Last post  Boffin99 Comments Created with Sketch.  4  Views Created with Sketch.  1.7K 
IXC 26/11/24 0 291
26/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  291 
IXC 26/11/24 0 348
26/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  348 
IXC 17/10/24 0 374
17/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  374 
IXC 14/10/24 0 417
14/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  417 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4D and Half Year Report
07 Feb 09:30
 
Quarterly Activities/Appendix 4C Cash Flow Report
22 Jan 09:02
 
Invex Receives $0.22m R&D Tax Rebate from UK Government
20 Jan 09:25
 
Improved Neuronal Cell Survival in 3D Model of Alzheimer's
16 Dec 09:18
 
Results of Meeting
26 Nov 15:25
 
Chair's Address to Shareholders
26 Nov 13:23
 
View More arrow Created with Sketch.
(20min delay)
Last
7.3¢
Change
0.000(0.00%)
Mkt cap ! $5.486M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 5575 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 42500 2
View Market Depth
Last trade - 16.12pm 07/02/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.